about
Regulation of protein synthesis by hypoxia via activation of the endoplasmic reticulum kinase PERK and phosphorylation of the translation initiation factor eIF2alpha.The clinical importance of assessing tumor hypoxia: relationship of tumor hypoxia to prognosis and therapeutic opportunitiesThe tumor as an organ: comprehensive spatial and temporal modeling of the tumor and its microenvironmentOverhauser enhanced magnetic resonance imaging for tumor oximetry: coregistration of tumor anatomy and tissue oxygen concentration.Re-oxygenation of hypoxic simian virus 40 (SV40)-infected CV1 cells causes distinct changes of SV40 minichromosome-associated replication proteins.Disparate responses of tumour vessels to angiotensin II: tumour volume-dependent effects on perfusion and oxygenation.Blood flow and oxygenation status of human tumors. Clinical investigations.Regulation of HIF-1alpha and VEGF by miR-20b tunes tumor cells to adapt to the alteration of oxygen concentration.FBP1 expression is associated with basal-like breast carcinomaQuantitative assessment of hypoxia subtypes in microcirculatory supply units of malignant tumors using (immuno-)fluorescence techniques.Imaging hypoxia in gliomas.Gene expression profiling of the long-term adaptive response to hypoxia in the gills of adult zebrafish.Targeting the tumor vasculature: a strategy to improve radiation therapy.Modulation of the tumor vasculature and oxygenation to improve therapyDevelopment of (99m)Tc-N4-NIM for molecular imaging of tumor hypoxia.Hypoxia Strongly Affects Mitochondrial Ribosomal Proteins and Translocases, as Shown by Quantitative Proteomics of HeLa Cells.Her2/neu signaling blockade improves tumor oxygenation in a multifactorial fashion in Her2/neu+ tumors.Blood flow responses to mild-intensity exercise in ectopic vs. orthotopic prostate tumors; dependence upon host tissue hemodynamics and vascular reactivity.Taking advantage of tumor cell adaptations to hypoxia for developing new tumor markers and treatment strategies.Novel imaging provides new insights into mechanisms of oxygen transport in tumors.Pathophysiological and vascular characteristics of tumours and their importance for hyperthermia: heterogeneity is the key issue.Prolyl hydroxylase and hypoxia inducible factor: potential targets for cancer therapy.The impact of tumor microenvironment on cancer treatment and its modulation by direct and indirect antivascular strategies.The role of non-hematopoietic stromal cells in the persistence of inflammation.Correlation Between Hypoxia Proteins and EPR-Detected Hypoxia in Tumors.Mechanism of tumour vascularization in experimental lung metastases.Hypoxia blocks in vivo initiation of simian virus 40 replication at a stage preceding origin unwinding.Transformed cells require continuous activity of RNA polymerase II to resist oncogene-induced apoptosis.Gene delivery to hypoxic cells in vitro.Rise of oxygenation in cervical lymph node metastasis during the initial course of radiochemotherapy.Fast control of DNA replication in response to hypoxia and to inhibited protein synthesis in CCRF-CEM and HeLa cells.Radiotherapy in combination with vascular-targeted therapies.Role of protein kinase Cdelta in transmitting hypoxia signal to HSF and HIF-1.In Vivo Application of Proton-Electron Double-Resonance Imaging.Co-imaging of the tumor oxygenation and metabolism using electron paramagnetic resonance imaging and 13-C hyperpolarized magnetic resonance imaging before and after irradiation.
P2860
Q24540258-B6471E2B-8DBD-46CF-8C4C-140163A8E13BQ27025579-29B4CB81-E520-41AC-B79B-EBB31B0995A7Q27318697-80FF9606-EBC2-4A36-ABAA-7FB101138953Q30675008-F95C3504-12B9-4429-AAB3-70009C4710F1Q30835095-49A47B22-AE81-427A-8BEA-2A5433735DA5Q31791086-0664DD4B-4EE5-4EF7-92AA-9215268D10E5Q31913190-20BF76F4-04E9-47F9-99E7-F4C424C37394Q33515259-FDBE6715-2BEB-42B5-9065-8B868D09B7C5Q33686009-DB7FD693-FE4F-4405-ABCC-C8AA888EF46BQ33855996-D812939D-6CE1-4EFC-91C4-C9AB2F6D6FA1Q34203937-2B52233D-A5F2-4AC7-896D-2C74F638A1DEQ34430831-87ACCD3D-D81E-4FB9-A683-2B907DFAF27AQ35728789-02A9CC55-76EF-48DF-A445-ABA834125BD7Q35920685-0577F234-3B6A-46C0-AFF3-994B9169D63DQ36036719-9D8A7F54-EF98-4D63-A08E-48CEF6DDCD13Q36066589-BF5A7628-5D7B-41BD-A679-5E6D9D6FF88AQ37076890-7A953F90-F68A-48C3-8838-DED39F2C9B7CQ37139742-ECF9BF13-F45E-4F1E-B388-CCB91D65942FQ37426436-907C6C3A-2E9F-4173-A376-14CA7335B9B0Q37515804-5431B457-0A44-4A6D-8ABD-A350906B9D2AQ37719535-9254BC33-982F-43B6-971F-D312DEF4F1CAQ37827854-CB744717-3562-4FA3-92B4-724A81965263Q38028791-86B7E4E5-97A1-4D72-AF8C-A5CDB53F57C9Q38075556-366F4F6A-19B8-481B-BB60-634B2F4EDD93Q38689958-D5C84980-C0F7-4459-82EF-88147B5EDD74Q38947459-38D96667-F5AF-4D21-9C38-8D8D17025028Q39551889-3C8E6AA8-E8C4-4024-B3B8-20D3A6AFB089Q40024169-5277A05B-BF1D-418A-90EA-325808A1F671Q40752310-CC5E84AB-24F2-4C8B-B220-A32CCB4ACC96Q40788000-1CF35BC1-C80C-4EE7-A486-736D62B6CD77Q40901853-A3257B57-26B6-4E72-B016-17A5EFDB8841Q42203737-36425068-8391-466B-83C2-687C5D1064F2Q43652298-67428EDF-5ACC-438F-A99F-18735D655727Q45069548-88E5B16A-EB1E-46FF-B382-B197163B7290Q54964454-884E7BFC-04C2-42DE-8779-352026E52E91
P2860
description
1996 nî lūn-bûn
@nan
1996 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Hypoxic Stress Proteins: Survival of the Fittest.
@ast
Hypoxic Stress Proteins: Survival of the Fittest.
@en
type
label
Hypoxic Stress Proteins: Survival of the Fittest.
@ast
Hypoxic Stress Proteins: Survival of the Fittest.
@en
prefLabel
Hypoxic Stress Proteins: Survival of the Fittest.
@ast
Hypoxic Stress Proteins: Survival of the Fittest.
@en
P1476
Hypoxic Stress Proteins: Survival of the Fittest.
@en
P2093
Giaccia AJ
P356
10.1016/S1053-4296(96)80035-X
P577
1996-01-01T00:00:00Z